Tango Therapeutics
Approach
Pipeline
Leadership
Join Us
News + Events
Contact
Home
Our Approach
Pipeline
Leadership
Join Us
News + Events
Contact
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor
Press Release
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor